Harvard Drug Group

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Harvard Drug Group - overview

Location

Livonia, MI, US

Primary Industry

Pharmaceuticals

About

Harvard Drug Group provide affordable brand and generic pharmaceuticals. They also give services to institutional clients, such as, hospital central-purchasing agents, long-term-care facilities, and government clients through its "Major" label of generic drugs.


Current Investors

Friedman Capital

Primary Industry

Pharmaceuticals

Sub Industries

Government, Drug Stores/Convenience Stores, Healthcare, Pharmaceuticals

Website

www.theharvarddruggroup.com

Company Stage

Acquired

Total Amount Raised

Subscriber access only

Harvard Drug Group - financials

Fiscal Year EndedJan 01, 2007Jan 01, 2008Jan 01, 2009Jan 01, 2010
Revenue (USD)400,000,000---
% Revenue Growth (YoY)----
EBITDA (USD)----
Operating Income (USD)----
Operating Margin----
% EBITDA Margin----
NET Income (USD)----
% Net Margin----

Harvard Drug Group - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Trade SaleCompletedHarvard Drug Group-
Add-onCompletedSpectrum Pharmacy Products-
Secondary BuyoutCompletedHarvard Drug Group-
RecapitalisationCompletedHarvard Drug Group-
BuyoutCompletedHarvard Drug Group-

Displaying 1 - 5 of 5

Harvard Drug Group - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.